Treatment delays in non-small cell lung cancer and their prognostic implications

Journal of Thoracic Oncology

Volumn 6, Issue 7, 2011, Pages 1254-1259

  Diaconescu, Razvan ^a   Lafond, Chantal ^a   Whittom, Renaud ^a  

^a HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

Author keywords

Non small cell; Standard treatment; Survival; Treatment delays

Indexed keywords

CARBOPLATIN; CISPLATIN; DOCETAXEL; ERLOTINIB; ETOPOSIDE; GEMCITABINE; NAVELBINE; PACLITAXEL; PEMETREXED; PROTEIN TYROSINE KINASE INHIBITOR;

ADULT; ADVANCED CANCER; AGE; AGED; ARTICLE; BRAIN METASTASIS; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHEMORADIOTHERAPY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HOSPICE CARE; HUMAN; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; PROGNOSIS; RADIOGRAPHY; RETROSPECTIVE STUDY; SEX DIFFERENCE; SMOKING; THERAPY DELAY;

EID: 79959898639     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e318217b623     Document Type: Article

References (21)

1. Ferlay J, Shin HR, Bray F, et al. GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10. Lyon, France: International Agency for Research on Cancer, 2010. Available at: Http://globocan.iarc.fr. Accessed October 19, 2010.
2. Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010. CA Cancer J Clin 2010;60:277-300.
3. Canadian Cancer Society's Steering Committee. Canadian Cancer Statistics 2010. Toronto, Canada: Canadian Cancer Society, 2010. Available at: Www.cancer.ca. Accessed October 19, 2010.
4. Alberts WM; American College of Chest Physicians. Diagnosis and management of lung cancer executive summary: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007;132:1S-19S. (Pubitemid 47502795)
5. Steinbrook R. Private health care in Canada. N Engl J Med 2006;354: 1661-1664.
6. Brundage MD, Davies D, Mackillop WJ. Prognostic factors in non-small cell lung cancer: A decade of progress. Chest 2002;122:1037-1057.
7. Mandrekar SJ, Schild SE, Hillman SL, et al. A prognostic model for advanced stage nonsmall cell lung cancer. Pooled analysis of North Central Cancer Treatment Group trials. Cancer 2006;107:781-792. (Pubitemid 44232670)
8. Rossi A, Galetta D, Gridelli C. Biological prognostic and predictive factors in lung cancer. Oncology 2009;77(Suppl 1):90-96.
9. Jackman DM, Miller VA, Cioffredi LA, et al. Impact of epidermal growth factor receptor and KRAS mutations on clinical outcomes in previously untreated non-small cell lung cancer patients: Results of an online tumor registry of clinical trials. Clin Cancer Res 2009;15:5267-5273.
10. Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest 1997;111:1710-1717. (Pubitemid 27260107)
11. Bach PB. Is our natural-history model of lung cancer wrong? Lancet Oncol 2008;9:693-697. (Pubitemid 351878055)
12. Arriagada R, Bergman B, Dunant A, et al. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 2004;350:351-360. (Pubitemid 38101630)
13. Arriagada R, Dunant A, Pignon JP, et al. Long-term results of the international adjuvant lung cancer trial evaluating adjuvant Cisplatinbased chemotherapy in resected lung cancer. J Clin Oncol 2010;28: 35-42.
14. Myrdal G, Lambe M, Hillerdal G, et al. Effect of delays on prognosis in patients with non-small cell lung cancer. Thorax 2004;59:45-49. (Pubitemid 38067971)
15. Salomaa ER, Sällinen S, Hiekkanen H, et al. Delays in the diagnosis and treatment of lung cancer. Chest 2005;128:2282-2288. (Pubitemid 41507570)
16. Virally J, Choudat L, Chebbo M, et al. [Epidemiology and delays in the management of 355 patients with lung cancer]. Rev Mal Respir 2006; 23:43-48.
17. Comber H, Cronin DP, Deady S, et al. Delays in treatment in the cancer services: Impact on cancer stage and survival. Ir Med J 2005;98:238-239. (Pubitemid 41582080)
18. Jacot W, Colinet B, Bertrand D, et al. Quality of life and comorbidity score as prognostic determinants in non-small-cell lung cancer patients. Ann Oncol 2008;19:1458-1464.
19. Soni MK, Cella D, Masters GA, et al. The validity and clinical utility of symptom monitoring in advanced lung cancer: A literature review. Clin Lung Cancer 2002;4:153-160. (Pubitemid 36054494)
20. Yorio JT, Xie Y, Yan J, et al. Lung cancer diagnostic and treatment intervals in the United States: A health care disparity? J Thorac Oncol 2009;4:1322-1330.
21. Friberg S, Mattson S. On the growth rates of human malignant tumors: Implications for medical decision making. J Surg Oncol 1997;65:284-297. (Pubitemid 27355857)